PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | |infection |
| Sentences | 1297 |
| PubMedID- 26357635 | The afc8 and a2/nsg/fas humanized mouse models have both human liver and human immune cells, and these models support hcv and hbv liver infection, respectively, leading to viral hepatitis and liver fibrosis.117,118 these animal models provide an attractive opportunity to study virus induced liver fibrosis. |
| PubMedID- 23845776 | Background: hepatocellular carcinoma (hcc) associated to infection with hepatitis c virus (hcv) has become the fastest-rising cause of cancer-related deaths. |
| PubMedID- 24656052 | infection with neuroadapted mouse hepatitis virus strain jhm was also reported to exacerbate ad-like pathology in a transgenic mouse ad model . |
| PubMedID- 21994691 | An estimated 75% of all hcc cases are due to chronic infection with hepatitis b (hbv) or hepatitis c (hcv) viruses, and the incidence rate of hcc is predicted to increase in western countries until the 2020s due to hcv infection . |
| PubMedID- 24621321 | Chronic infection with hepatitis c virus (hcv) affects up to 170 million individuals worldwide 1 and may lead to progressive hepatic fibrosis and cirrhosis, with risk of liver failure and hepatocellular carcinoma. |
| PubMedID- 21472121 | Co-infection with hepatitis b and hepatitis c viruses is frequent in highly endemic areas. |
| PubMedID- 24478542 | Viral infection with hepatitis c virus (hcv) has a high propensity in becoming chronic and it is the major cause of hepatocellular carcinoma (hcc) worldwide. |
| PubMedID- 26186636 | Chronic infection with the hepatitis c virus (hcv) is a cause of cirrhosis and hepatocellular carcinoma worldwide. |
| PubMedID- 23202511 | Epidemiological studies indicate that chronic infection with hepatitis b virus (hbv) is the leading cause for the development of hepatocellular carcinoma (hcc) 1. |
| PubMedID- 23433483 | Chronic infection with hepatitis b or c viruses and alcohol consumption are considered the most important risk factors for liver cancer. |
| PubMedID- 21682827 | Although chronic infection with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) are the most important risk factors for the development of hepatocellular carcinoma (hcc) worldwide, the proportion of hcc patients negative for the hepatitis b surface antigen and hepatitis c antibody, so-called "non-b non-c hcc", is rapidly increasing, especially in japan. |
| PubMedID- 21371325 | Occult hbv infection has been associated with cryptogenic chronic hepatitis and hcc. |
| PubMedID- 22422696 | Co-infection with hiv and hepatitis b virus (hbv) has serious long-term consequences. |
| PubMedID- 26282123 | infection with hepatitis e virus (hev) can be clinically inapparent or produce symptoms and signs of hepatitis of varying severity and occasional fatality. |
| PubMedID- 20944890 | In addition, there was a higher frequency of co-infection with other viruses (hepatitis b and c and human t-lymphotropic viruses) in individuals with crf31_bc, compared to other subtypes. |
| PubMedID- 25170454 | infection with hepatitis b virus (hbv) can progress to chronic liver disease, including cirrhosis and hepatocellular carcinoma (hcc), which ranks as the third cause of cancer deaths worldwide. |
| PubMedID- 24839620 | Background: chronic infection with hepatitis c virus (hcv) is a major cause of cirrhosis, hepatocellular carcinoma and liver transplantation. |
| PubMedID- 23740063 | Introduction: autoantibodies are often produced during infection with chronic hepatitis c virus (hcv), but it remains controversial whether they influence the biochemical profile and histological features of this disease. |
| PubMedID- 26241457 | infection with the hepatitis b virus (hbv) is a public health problem in terms of morbidity and mortality. |
| PubMedID- 24822024 | Chronic infection with hepatitis c virus (hcv) affects more than 170 million people worldwide and is a leading cause of anticipated liver-related death due to the development of cirrhosis and its complications.1 in the last 10 years, standard of care anti-hcv treatment has been founded on the combination of peginterferon (peg-ifn) plus ribavirin (rbv), whose main disadvantages were suboptimal rates of sustained virological response (svr) in difficult-to-treat patients (hcv genotype 1–4, advanced liver fibrosis) and, most of all, side effects profile resulting in poor tolerability and treatment contraindication in some patient subsets (decompensated liver disease and autoimmune disorders).2 the recent availability of culture cell models provided deeper insight in understanding hcv life cycle and was the basis for the development of new drugs targeting non-structural hcv proteins involved in viral replication process, such as ns3 and ns5a/b (figure 1 and table 1). |
| PubMedID- 21394322 | Since the introduction of highly active antiretroviral therapy (haart) in 1996 for human immunodeficiency virus (hiv)-infected patients, the incidence of liver diseases secondary to co-infection with hepatitis c has increased. |
| PubMedID- 22406819 | Association of cytomegalovirus infection and disease with recurrent hepatitis c after liver transplantation. |
| PubMedID- 26239319 | Chronic infection with hepatitis b virus (hbv) is a major risk for development of hepatocellular carcinoma (hcc), which is the fifth most common cancer and a leading global cause of mortality. |
| PubMedID- 22212930 | Persistent infection with hepatitis c virus (hcv) is a major risk for the development of hepatocellular carcinoma (hcc). |
| PubMedID- 24818148 | Several etiological factors have been identified including chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv), prolonged exposure to aflatoxin b1 . |
| PubMedID- 23715963 | infection with the hepatitis b virus (hbv) is a significant public health concern in the us, disproportionately affecting americans of asian, native hawaiian and pacific islander descent, despite the availability of a simple blood test, approved treatments, and an effective vaccine. |
| PubMedID- 24008295 | Persistent infection with hepatitis c virus (hcv) is a major risk toward development of hepatocellular carcinoma (hcc). |
| PubMedID- 23913498 | Pattern and risk factors for partner infection with hepatitis b virus in a prevention of mother-to-child transmission programme. |
| PubMedID- 24807840 | In thisstudy, a comprehensive comparison of fucosylation aberration in serumhp was performed between hcc and cirrhosis patients of the three mostcommon etiologies, infection with hepatitis b virus (hbv), infectionwith hepatitis c virus (hcv), and heavy alcohol consumption (alc).we have described herein a quantitative mass spectrometry-based approachto determine fucosylation alterations of serum hp in 104 individualpatients, including 50 hcc, 40 cirrhosis, and 14 healthy controls.maldi-qit-tof ms analysis showed that both fucosylated and branched n-glycan structures were distinctly increased in patientswith cirrhosis and hcc compared to healthy subjects, which is consistentwith previous studies.11 singly fucosylatedtriantennary glycan, with antennary fucosylation, was found to besignificantly increased in hcc and cirrhosis. |
| PubMedID- 22737659 | Gaining weight after transplantation, particularly among kidney transplant recipients, and infection with the hepatitis c virus are modifiable risk factors for the development of ptdm. |
| PubMedID- 22200181 | Exclusion criteria included co-infection with hepatitis b virus (hbv) and/or schistosome infection. |
| PubMedID- 25647607 | Exclusion criteria included co-infection with hepatitis a, c, d, or e viruses or hiv, decompensated liver diseases or hepatocellular carcinoma, a history of alcohol or drug abuse within 1 year prior to enrollment in the study, other possible causes of chronic liver damage, and previous treatment for chronic hepatitis b. serum samples were taken from all patients at baseline and week 48, and stored at −70°c until used for the measurement of hbv dna and cccdna levels. |
| PubMedID- 25982058 | (a) comparison of serum soluble sra concentrations in healthy controls (hc) (n = 22), subjects in the immune tolerance (it) (n = 28) and inactive carrier (ic) (n = 33) stages of a chronic hbv infection, and patients with hbeag-positive chronic hepatitis b (chb) (n = 29). |
| PubMedID- 25567678 | Specific cd8(+) t cells (ctls) play an important role in resolving protracted infection with hepatitis b and c virus in humans and lymphocytic choriomeningitis virus (lcmv) in mice. |
| PubMedID- 25795587 | The aim was to investigate the antiviral state of hdv infected human hepatocytes in the setting of co-infection with hepatitis b virus (hbv) compared to hbv mono-infection using human liver chimeric mice. |
| PubMedID- 24655358 | We hypothesize that subclinical infection of children with hepatitis a or the low likelihood of adults or children with mild influenza-like illness to seek medical attention may account for low numbers of these 2 vpi reported from geosentinel sites. |
| PubMedID- 24949003 | infection with hepatitis viruses is relatively common among patients with hematologic malignancies. |
| PubMedID- 23304252 | Co-infection with viral hepatitis b or c has also been associated with hepatotoxicity from antiretroviral therapy in some but not all studies . |
| PubMedID- 25705875 | infection with hepatitis c virus (hcv) is a worldwide public health problem, a major cause of liver cirrhosis and hepatocellular carcinoma, and has been considered the leading indication for liver transplantation 1. |
| PubMedID- 26429337 | Patients were not excluded on the basis of previous treatment for chc, co-infection with hiv or hepatitis b, or active or past substance or alcohol use. |
| PubMedID- 23958588 | Co-infection with other hepatitis viruses and low cd4-nadir, but not hbv-g co-infection, were associated with a 5-year risk of fibrosis progression. |
| PubMedID- 22869395 | Background and aim: hepatocellular carcinoma (hcc) is the most frequent form of primary liver cancer and chronic infection with hepatitis c virus is one of the main risk factors for hcc. |
| PubMedID- 23874760 | In this study, the exclusion criteria included co-infection with hcv, hepatitis d virus, hepatitis g virus and/or human immunodeficiency virus, other autoimmune liver disease, hepatocellular carcinoma, liver transplantation and metabolic liver disease. |
| PubMedID- 20714136 | Conclusion: our results support that infection with hepatitis c in patients with glomerulonephritis is associated with an increased risk of progression of ckd. |
| PubMedID- 24550249 | Since 2005, data have also been collected on: co-infection with hepatitis b or c virus; alcohol and tobacco use; and non hiv-related biomarkers. |
| PubMedID- 21790072 | Viral hepatitis associated with adenoviral infection has been reported in california sea lions zalophus californianus admitted to rehabilitation centers along the california coast since the 1970s. |
| PubMedID- 23595580 | Increased expression of mmps occurs during development of hepatocellular carcinoma (hcc) in humans following infection with hepatitis b virus (hbv). |
| PubMedID- 25285757 | Chronic infection with hepatitis c virus (hcv) may lead to b cell activation and transformation into non-hodgkin lymphoma (nhl). |
| PubMedID- 24416131 | infection with hepatitis c virus (hcv) is one of the major risk factors for the development of hcc 2. |
| PubMedID- 23028319 | Chronic infection with hepatitis b virus (hbv) can lead to liver failure and cirrhosis; it is also the leading cause of hepatocellular carcinoma. |